Hasan Mukhtar Selected Research

Tea

12/2018	Tea Polyphenols in Promotion of Human Health.
1/2018	Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
5/2017	A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.
11/2014	Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.
2/2014	Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.
3/2013	Modulation of signaling pathways in prostate cancer by green tea polyphenols.
1/2013	Green tea polyphenols and cancer chemoprevention of genitourinary cancer.
1/2013	Tea and health: studies in humans.
1/2013	Human cancer chemoprevention: hurdles and challenges.
4/2011	Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hasan Mukhtar Research Topics

Disease

142	Neoplasms (Cancer) 01/2022 - 01/2002
76	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 02/2002
27	Carcinogenesis 12/2019 - 01/2002
18	Skin Neoplasms (Skin Cancer) 01/2015 - 01/2002
15	Carcinoma (Carcinomatosis) 01/2019 - 05/2002
15	Melanoma (Melanoma, Malignant) 10/2018 - 04/2005
11	Inflammation (Inflammations) 01/2019 - 02/2003
11	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2003
11	Adenocarcinoma 03/2011 - 01/2003
9	Hyperplasia 01/2019 - 01/2003
7	Edema (Dropsy) 11/2010 - 11/2003
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 03/2008
5	Colonic Neoplasms (Colon Cancer) 12/2019 - 06/2005
5	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 10/2007
5	Skin Diseases (Skin Disease) 01/2019 - 11/2003
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 07/2007
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2015 - 08/2003
3	Cardiotoxicity 01/2020 - 01/2020
3	Leukemia 01/2019 - 10/2007
3	Disease Progression 10/2018 - 02/2006
3	Dermatitis 01/2018 - 03/2008
3	Lung Neoplasms (Lung Cancer) 01/2017 - 04/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2009 - 11/2005
2	Obesity 12/2019 - 04/2015
2	Atherosclerosis 01/2018 - 01/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 04/2012

Drug/Important Bio-Agent (IBA)

49	TeaIBA 12/2018 - 02/2002
34	PolyphenolsIBA 01/2020 - 02/2002
29	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
22	AntioxidantsIBA 01/2022 - 04/2002
21	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2020 - 02/2002
21	fisetinIBA 12/2019 - 05/2008
16	FlavonoidsIBA 12/2019 - 05/2002
15	AndrogensIBA 01/2021 - 05/2002
15	NF-kappa B (NF-kB)IBA 01/2014 - 05/2002
13	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2004
11	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 10/2005
10	TriterpenesIBA 10/2018 - 11/2005
9	Phosphotransferases (Kinase)IBA 01/2019 - 08/2004
9	Therapeutic UsesIBA 01/2016 - 04/2004
9	lupeolIBA 11/2013 - 07/2004
9	Guanosine Triphosphate (GTP)IBA 03/2013 - 01/2003
8	delphinidinIBA 10/2017 - 08/2008
8	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2015 - 04/2005
7	Pharmaceutical PreparationsIBA 01/2022 - 08/2003
7	ResveratrolIBA 01/2020 - 03/2008
7	PhytochemicalsIBA 01/2019 - 01/2008
7	Biological ProductsIBA 05/2017 - 01/2007
7	Messenger RNA (mRNA)IBA 01/2017 - 01/2003
7	Anthocyanins (Anthocyanin)IBA 01/2015 - 01/2005
6	CyclinsIBA 01/2016 - 02/2003
6	Insulin-Like Growth Factor I (IGF-1)IBA 03/2012 - 12/2004
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2010 - 07/2002
6	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2009 - 07/2002
5	CytokinesIBA 01/2019 - 07/2009
5	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 11/2010 - 03/2004
4	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 10/2008
4	EnzymesIBA 01/2020 - 07/2002
4	CateninsIBA 11/2013 - 10/2010
4	Sunscreening Agents (Sunscreens)IBA 03/2008 - 04/2002
4	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2006 - 04/2002
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2005 - 03/2003
3	LipidsIBA 01/2020 - 11/2003
3	Ethanol (Ethyl Alcohol)IBA 01/2020 - 07/2007
3	CurcuminIBA 01/2020 - 10/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 07/2013
3	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 04/2015
3	Matrix Metalloproteinases (MMPs)IBA 10/2018 - 01/2003
3	LigandsIBA 01/2018 - 02/2009
3	ChitosanIBA 01/2018 - 02/2014
3	Imiquimod (Aldara)FDA LinkGeneric 01/2018 - 01/2016
3	AntigensIBA 01/2017 - 03/2013
3	SeleniumIBA 06/2014 - 11/2008
3	Vitamin E FDA LinkGeneric 06/2014 - 11/2008
3	Calcium-Binding ProteinsIBA 05/2013 - 01/2003
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2012 - 02/2004
3	Cyclin D1IBA 10/2010 - 04/2005
3	Drinking WaterIBA 03/2009 - 03/2007
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2008 - 03/2005
3	sanguinarineIBA 07/2007 - 08/2003
3	cytoplasmic antiproteinaseIBA 10/2006 - 02/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2006 - 01/2003
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 03/2003
2	Free RadicalsIBA 01/2020 - 01/2020
2	dikanutIBA 01/2020 - 01/2020
2	CatalaseIBA 01/2020 - 03/2012
2	QuercetinIBA 01/2020 - 01/2016
2	AcidsIBA 10/2018 - 04/2015
2	ChemokinesIBA 01/2018 - 10/2017
2	plectranthoic acidIBA 01/2018 - 01/2016
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2015 - 09/2004
2	Transcription Factors (Transcription Factor)IBA 01/2015 - 03/2004
2	AMP-Activated Protein KinasesIBA 12/2014 - 09/2008

Therapy/Procedure

49	Chemoprevention 10/2017 - 01/2002
36	Therapeutics 01/2022 - 05/2002
9	Drug Therapy (Chemotherapy) 12/2016 - 10/2005
8	Oral Administration 02/2014 - 10/2005
3	Intraperitoneal Injections 01/2021 - 01/2015
3	Radiotherapy 04/2015 - 01/2003
2	Diet Therapy (Therapy, Diet) 04/2015 - 03/2008